Provention Bio Inc (PRVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PRVB | BEAM | PTGX | ||
| Company | Provention Bio Inc | Beam Therapeutics Inc | Protagonist Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 24.99 | 28.77 | 40.43 | ||
| High | 25.00 | 29.12 | 40.44 | ||
| Low | 24.98 | 28.00 | 38.90 | ||
| Last | 24.98 | 28.81 | 39.30 | ||
| Change | +0.75 | +0.11 | -1.30 | ||
| % Change | +3.10% | +0.38% | -3.20% | ||
| Volume | 9,124,100 | 263,500 | 249,300 | ||
| 20-Day Average Volume | 2,505,925 | 1,139,090 | 691,190 | ||
| Previous Close | 24.23 | 28.70 | 40.60 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 24.34 | 27.63 | 41.45 | ||
| 20-Day Raw Stochastic | 98.15% | 63.74% | 8.73% | ||
| 20-Day Relative Strength | 79.66% | 55.42% | 42.35% | ||
| Weighted Alpha | +19.60 | +4.07 | +50.28 | ||
| Today's Opinion | 100% Buy | 72% Buy | 8% Sell | ||
| Previous Opinion | 88% Buy | 72% Buy | 8% Buy | ||
| Last Month's Opinion | 100% Buy | 24% Sell | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.21% since 04/19/23 | +0.80% since 12/17/24 | -3.42% since 12/17/24 | ||
| Low | 24.20 on 04/25/23 | 24.96 on 12/19/24 | 38.61 on 12/19/24 | ||
| High | 25.00 on 04/26/23 | 29.52 on 12/23/24 | 41.68 on 12/20/24 | ||
| 1-Month | |||||
| %Chg | +4.56% since 03/24/23 | +15.01% since 11/22/24 | -15.41% since 11/22/24 | ||
| Low | 23.82 on 03/27/23 | 24.96 on 12/19/24 | 38.61 on 12/19/24 | ||
| High | 25.00 on 04/26/23 | 31.00 on 12/10/24 | 48.29 on 11/25/24 | ||
| 3-Month | |||||
| %Chg | +186.80% since 01/26/23 | +16.31% since 09/24/24 | -15.63% since 09/24/24 | ||
| Low | 6.59 on 03/10/23 | 21.14 on 10/24/24 | 33.31 on 11/19/24 | ||
| High | 25.00 on 04/26/23 | 32.29 on 11/11/24 | 48.89 on 10/28/24 | ||
| 6-Month | |||||
| %Chg | +279.64% since 10/26/22 | +16.03% since 06/24/24 | +22.77% since 06/24/24 | ||
| Low | 6.38 on 10/28/22 | 21.14 on 10/24/24 | 30.67 on 06/26/24 | ||
| High | 25.00 on 04/26/23 | 34.09 on 07/26/24 | 48.89 on 10/28/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,367,629 | 2,385,641 | 2,342,201 | ||
| Shares Outstanding, K | 94,781 | 82,806 | 59,598 | ||
| Annual Sales | 12,900,000 | 377,710,000 | 60,000,000 | ||
| Annual Net Income | -113,570,000 | -132,530,000 | -78,960,000 | ||
| Last Quarter Sales | 10,810,000 | 14,270,000 | 4,680,000 | ||
| Last Quarter Net Income | -33,280,000 | -96,670,000 | -33,210,000 | ||
| 60-Month Beta | 2.47 | 1.90 | 2.18 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.38 on 03/29/23 | -1.17 on 11/05/24 | -0.54 on 11/07/24 | ||
| Latest Earnings Date | 05/04/23 | 11/05/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | 02/04/14 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 15.26 | ||